
Loading, please wait...

Loading, please wait...

Brucellar Spondylodiscitis remains a significant diagnostic challenge for clinicians worldwide, particularly when it presents as a late-stage reactivation. Recently, a case report detailed a 35-year-old female patient from Syria, residing in Brazil, who developed chronic back pain. Remarkably, she had a history of brucellosis that was diagnosed and treated twenty years earlier. This case emphasizes the need for high clinical suspicion in patients with an epidemiological history, even decades after the primary event.
The patient presented with chronic back pain, headache, and discomfort in her left upper limb. Notably, she did not experience fever or weight loss, which frequently leads clinicians to overlook infectious etiologies. Magnetic resonance imaging (MRI) revealed a pathological fracture of the T8 vertebral body. Initially, histopathological examination showed a chronic granulomatous inflammatory process with necrosis. Because these findings often overlap with other diseases, the medical team first treated the condition as bone tuberculosis. However, subsequent laboratory confirmation finally identified Brucella as the causative agent. Consequently, the team shifted the therapeutic approach to target brucellosis specifically.
The treatment of spinal brucellosis requires a multi-drug regimen to ensure complete eradication and prevent further relapses. For this specific case, the patient received a combination of amikacin, rifampicin, and doxycycline for nine months. This prolonged duration is often necessary for bone-involved infections. Similarly, various studies suggest that triple-antibiotic therapy provides better outcomes compared to dual therapy in complicated presentations. Monitoring clinical improvement and radiological resolution is essential during the follow-up period. Furthermore, clinicians must distinguish this condition from spinal tuberculosis, as the pharmaceutical choices and treatment timelines differ considerably. Successful recovery in this patient was eventually confirmed through clinical and laboratory improvement.
Yes, brucellosis can remain latent in the body and manifest as localized infections, such as spondylodiscitis, many years later. This often occurs due to the pathogen's ability to survive within the reticuloendothelial system.
While both cause vertebral destruction, brucellosis typically shows more focal bone destruction and limited paravertebral involvement. Conversely, tuberculosis often presents with larger psoas abscesses and more extensive multi-level vertebral damage.
Most guidelines recommend a minimum of 12 weeks of combination therapy, though complicated cases like spondylodiscitis often require 6 to 12 months of treatment to ensure full resolution.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional consultation. Refer to the latest local and national guidelines for clinical practice.
References
Kanebley M et al. Brucellar Spondylodiscitis 20 Years Post Infection. Am J Trop Med Hyg. 2026 Feb 17. doi: undefined. PMID: 41701984.
Pappas G, Akritidis N, Bosilkovski M, Tsianos E. Brucellosis. N Engl J Med. 2005 Jun 2;352(22):2325-36. doi: 10.1056/NEJMra050570.
Ulu-Kilic A, Karakas A, Erdem H, et al. Update on treatment options for spinal brucellosis. Clin Microbiol Infect. 2014;20(2):O75-O82. doi: 10.1111/1469-0691.12351.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A case report describes a 35-year-old patient who developed brucellar spondylodiscitis two decades after her initial infection, highlighting diagnostic pitf...
5 months ago

Emergency department overcrowding threatens patient safety and increases staff burnout. Adapting a staff-led vertical flow model with nurse-driven triage protocols in rural hospitals successfully decreases patient length of stay and reduces rates of patients leaving without being seen.
Today

A randomized double-blind non-inferiority trial shows haloperidol-ondansetron is non-inferior to dexamethasone-ondansetron for PONV prophylaxis after laparoscopic gynecological surgery, offering a safe, effective steroid-sparing alternative with reduced early postoperative pain.
Today

Following the admission of Union Health Minister JP Nadda to AIIMS Delhi for acute uneasiness, clinical teams utilized diagnostic coronary angiography and inpatient observation. This clinical review outlines acute triage pathways, procedural protocols, post-procedure observation, and long-term risk management.
Today

A recent study demonstrates the feasibility and clinical utility of nurse-led preoperative physical and cognitive training in reducing postoperative delirium among elderly hip surgery patients, emphasizing modifiable factors like bed rest and orientation comprehension.
Today

Diabetic kidney disease remains a major cause of renal failure despite renin-angiotensin system blockade. Learn how combining SGLT2 inhibitors, nonsteroidal MRAs, GLP-1 receptor agonists, and novel aldosterone synthase or endothelin inhibitors addresses residual cardiorenal risk.
Today